Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
Saved in:
| Title: | Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. |
|---|---|
| Authors: | Abdul-Aziz MH; Burns, Trauma and Critical Care Research Centre, Level 3, Ned Hanlon Building, Royal Brisbane and Women's Hospital, The University of Queensland, Herston, QLD, 4029, Australia. mohd.abdulaziz1@uqconnect.edu.au.; School of Pharmacy, International Islamic University of Malaysia, Kuantan, Pahang, Malaysia. mohd.abdulaziz1@uqconnect.edu.au., Sulaiman H; Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Mat-Nor MB; Department of Anaesthesiology and Intensive Care, School of Medicine, International Islamic University of Malaysia, Kuantan, Pahang, Malaysia., Rai V; Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Wong KK; Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Hasan MS; Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Abd Rahman AN; School of Pharmacy, International Islamic University of Malaysia, Kuantan, Pahang, Malaysia.; School of Pharmacy, The University of Queensland, Brisbane, Australia., Jamal JA; Department of Pharmacy, Hospital Tengku Ampuan Afzan, Kuantan, Malaysia., Wallis SC; Burns, Trauma and Critical Care Research Centre, Level 3, Ned Hanlon Building, Royal Brisbane and Women's Hospital, The University of Queensland, Herston, QLD, 4029, Australia., Lipman J; Burns, Trauma and Critical Care Research Centre, Level 3, Ned Hanlon Building, Royal Brisbane and Women's Hospital, The University of Queensland, Herston, QLD, 4029, Australia.; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia., Staatz CE; School of Pharmacy, The University of Queensland, Brisbane, Australia.; Australian Centre of Pharmacometrics, Brisbane, Australia., Roberts JA; Burns, Trauma and Critical Care Research Centre, Level 3, Ned Hanlon Building, Royal Brisbane and Women's Hospital, The University of Queensland, Herston, QLD, 4029, Australia. j.roberts2@uq.edu.au.; School of Pharmacy, The University of Queensland, Brisbane, Australia. j.roberts2@uq.edu.au.; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia. j.roberts2@uq.edu.au. |
| Source: | Intensive care medicine [Intensive Care Med] 2016 Oct; Vol. 42 (10), pp. 1535-1545. Date of Electronic Publication: 2016 Jan 11. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
